Xalkori Crizotinib 250mg

Xalkori Crizotinib 250mg

Curing cancer requires costly and effective treatment. The drug Xalkori (Crizotinib) - Xalkori (Crizotinib) is intended for the treatment of non-small cell lung cancer. The newest remedy has managed to prove itself perfectly in the treatment of a serious illness. Composition and properties The effective drug of the latest generation includes the active drug crizotinib, which is a selective inhibitor of tyrosine kinase and anaplastic lymphoma kinase. Also included in the drug are additional substances that promote better absorption of the drug. The latest generation drug stops the further development of a malignant tumor and kills cancer cells. As a result of the action of the agent, tumor cell structures are induced by crizotinib. Xalkori is a powerful anticancer drug that is often prescribed by doctors if previous lung cancer treatment has failed. The antitumor effect of the agent is dose-dependent. To buy a medicine Xalkori (Crizotinib) - Xalkori (Crizotinib) at a reduced price, contact our online pharmacy.

  • Pfizer

Price: $ 2600

Usefulness

Indications • ALK-positive non-small cell carcinoma; • ROS-1 positive lung cancer. Contraindications • hypersensitivity to the composition of the product; • pregnancy; • lactation; • childhood; • liver failure; • co-administration with CYP3A inhibitors.

Mode of application Taking this medication is independent of food intake. The capsule is swallowed without chewing. It is imperative to drink the medication with clean water. Doctors recommend a dose of the drug - 250 mg (2 times a day). Do not double the drug dosage when skipping the use of the drug. Dose adjustment depends on the severity of the CTCAE. With severe side effects, the drug is temporarily canceled. However, there are only positive reviews for Xalkori (Crizotinib) - Xalkori (Crizotinib) . The drug is well tolerated by the body. Adverse reactions • dizziness; • neuropathy; • decreased appetite; • nausea; • diarrhea; • constipation; • visual impairment.

©2020 CopyRight Onco24.com. All rights reserved.